These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16004553)

  • 1. Novel technology and the development of pharmacogenetics within the pharmaceutical industry.
    Gibson N; Jawaid A; March R
    Pharmacogenomics; 2005 Jun; 6(4):339-56. PubMed ID: 16004553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics research: a potential strategy for drug development.
    Wen JG; Wu L; Pu XX; He FZ; Liu MZ; Zhou HH; Zhang W
    Pharmazie; 2015 Jul; 70(7):437-45. PubMed ID: 26373203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics-based therapeutic recommendations--ready for clinical practice?
    Kirchheiner J; Fuhr U; Brockmöller J
    Nat Rev Drug Discov; 2005 Aug; 4(8):639-47. PubMed ID: 16056390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics in drug development.
    McCarthy AD; Kennedy JL; Middleton LT
    Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1579-88. PubMed ID: 16096107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNP market view: opportunities, technologies, and products.
    Wypgant M
    Biotechniques; 2002 Jun; Suppl():78-80, 82, 84 passim. PubMed ID: 12083402
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug discovery and development in the age of molecular medicine.
    Vallance P; Levick M
    Clin Pharmacol Ther; 2007 Oct; 82(4):363-6. PubMed ID: 17851574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rubicon Genomics, Inc.
    Langmore JP
    Pharmacogenomics; 2002 Jul; 3(4):557-60. PubMed ID: 12164778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing pharmacogenetic evidence throughout clinical development.
    Burns DK
    Clin Pharmacol Ther; 2010 Dec; 88(6):867-70. PubMed ID: 20981004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicos BioSciences.
    Milos P
    Pharmacogenomics; 2008 Apr; 9(4):477-80. PubMed ID: 18384261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics in drug discovery and development: a translational perspective.
    Roses AD
    Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparing for the revolution--pharmacogenomics and the clinical lab.
    Mehr IJ
    Pharmacogenomics; 2000 Feb; 1(1):1-4. PubMed ID: 11258591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.
    Miscio G; Paroni G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Piccininni C; Prisciandaro M; Ciavarella G; Daniele A; Bellomo A; Panza F; Di Mauro L; Greco A; Seripa D
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):751-765. PubMed ID: 31512953
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacogenetics and drug metabolism.
    Ball S; Borman N
    Nat Biotechnol; 1997 Oct; 15(10):925-6. PubMed ID: 9335033
    [No Abstract]   [Full Text] [Related]  

  • 15. Company profile: PGXIS Ltd.
    McCarthy A
    Pharmacogenomics; 2011 Sep; 12(9):1253-6. PubMed ID: 21919604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of pharmacogenomics for drug development.
    Kirk RJ; Hung JL; Horner SR; Perez JT
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PhRMA white paper on ADME pharmacogenomics.
    Williams JA; Andersson T; Andersson TB; Blanchard R; Behm MO; Cohen N; Edeki T; Franc M; Hillgren KM; Johnson KJ; Katz DA; Milton MN; Murray BP; Polli JW; Ricci D; Shipley LA; Vangala S; Wrighton SA
    J Clin Pharmacol; 2008 Jul; 48(7):849-89. PubMed ID: 18524998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DxS Ltd.
    Little S
    Pharmacogenomics; 2003 Jan; 4(1):97-101. PubMed ID: 12517290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics in Europe: barriers and opportunities.
    Gurwitz D; Zika E; Hopkins MM; Gaisser S; Ibarreta D
    Public Health Genomics; 2009; 12(3):134-41. PubMed ID: 19204415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.